Carlos Centeno

Summary

Country: Spain

Publications

  1. ncbi request reprint Delirium in advanced cancer patients
    Carlos Centeno
    Centro Regional de Cuidados Paliativos y Tratamiento del Dolor, Hospital Los Montalvos, Salamanca, Spain
    Palliat Med 18:184-94. 2004
  2. ncbi request reprint Effects of parenteral hydration in terminally ill cancer patients: a preliminary study
    Eduardo Bruera
    Department of Palliative Care and Rehabilitation Medicine, Unit 8, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 23:2366-71. 2005
  3. ncbi request reprint Intermittent subcutaneous methadone administration in the management of cancer pain
    Carlos Centeno
    Clinica Universitaria, Universidad de Navarra, Avenida Pio XII, 31008 Pamplona, Spain
    J Pain Palliat Care Pharmacother 19:7-12. 2005
  4. ncbi request reprint Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors
    Yago Nieto
    Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Biol Blood Marrow Transplant 13:1324-37. 2007

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Delirium in advanced cancer patients
    Carlos Centeno
    Centro Regional de Cuidados Paliativos y Tratamiento del Dolor, Hospital Los Montalvos, Salamanca, Spain
    Palliat Med 18:184-94. 2004
    ..Haloperidol is the most frequently used drug, and new neuroleptics such as risperidone or olanzapine are being tested with good results. Methylphenidate has been used for hypoactive delirium...
  2. ncbi request reprint Effects of parenteral hydration in terminally ill cancer patients: a preliminary study
    Eduardo Bruera
    Department of Palliative Care and Rehabilitation Medicine, Unit 8, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 23:2366-71. 2005
    ..Most patients with cancer develop decreased oral intake and dehydration before death. This study aimed to determine the effect of parenteral hydration on overall symptom control in terminally ill cancer patients with dehydration...
  3. ncbi request reprint Intermittent subcutaneous methadone administration in the management of cancer pain
    Carlos Centeno
    Clinica Universitaria, Universidad de Navarra, Avenida Pio XII, 31008 Pamplona, Spain
    J Pain Palliat Care Pharmacother 19:7-12. 2005
    ..Subcutaneous intermittent administration of methadone appears to be a useful alternative to oral administration in selected clinical situations when oral administration is not feasible...
  4. ncbi request reprint Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors
    Yago Nieto
    Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Biol Blood Marrow Transplant 13:1324-37. 2007
    ..The resulting gemcitabine/docetaxel/melphalan/carboplatin combination was highly active in refractory cancers and should be further tested in disease-specific trials...